US Penny Stocks To Watch In November 2024

In This Article:

As the U.S. stock market experiences fluctuations, with major indices like the S&P 500 and Nasdaq Composite seeing recent downturns, investors are keenly observing potential opportunities amid these shifts. Penny stocks, often associated with smaller or emerging companies, remain a relevant investment area despite their traditional label. With strong financial health as a key consideration, these stocks can present unique growth prospects for those looking to explore under-the-radar opportunities in today's dynamic market landscape.

Top 10 Penny Stocks In The United States

Name

Share Price

Market Cap

Financial Health Rating

BAB (OTCPK:BABB)

$0.827

$6.01M

★★★★★★

QuantaSing Group (NasdaqGM:QSG)

$3.08

$144.65M

★★★★★★

Golden Growers Cooperative (OTCPK:GGRO.U)

$4.50

$69.71M

★★★★★★

PHX Minerals (NYSE:PHX)

$3.56

$133.43M

★★★★★☆

So-Young International (NasdaqGM:SY)

$1.25

$90.8M

★★★★☆☆

Puma Biotechnology (NasdaqGS:PBYI)

$2.74

$134.5M

★★★★★★

LexinFintech Holdings (NasdaqGS:LX)

$3.22

$529.41M

★★★★★★

Better Choice (NYSEAM:BTTR)

$1.63

$2.97M

★★★★★★

CBAK Energy Technology (NasdaqCM:CBAT)

$0.8799

$79.14M

★★★★★☆

Zynerba Pharmaceuticals (NasdaqCM:ZYNE)

$1.30

$65.6M

★★★★★☆

Click here to see the full list of 738 stocks from our US Penny Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

LexinFintech Holdings

Simply Wall St Financial Health Rating: ★★★★★★

Overview: LexinFintech Holdings Ltd. operates in the People's Republic of China, offering online consumer finance services through its subsidiaries, with a market cap of approximately $529.41 million.

Operations: The company generates revenue from its online retailers segment, amounting to CN¥13.90 billion.

Market Cap: $529.41M

LexinFintech Holdings, operating in China's consumer finance sector, has seen fluctuations in financial performance and stock volatility. Despite a satisfactory net debt to equity ratio of 30.9% and strong interest coverage by EBIT, earnings have declined by 13.7% annually over five years with recent negative growth of -35.6%. The company reported revenue growth for the second quarter of CN¥3.64 billion but experienced a drop in net income to CN¥226.53 million from CN¥355.73 million last year due to a one-off loss impacting results significantly. The stock trades at a substantial discount relative to its estimated fair value, though profit margins have decreased recently.

NasdaqGS:LX Financial Position Analysis as at Nov 2024
NasdaqGS:LX Financial Position Analysis as at Nov 2024

FREYR Battery

Simply Wall St Financial Health Rating: ★★★★★★